Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathwaysFrancesca Bruzzese, Alfredo Budillon, Renato Franco et al.|Cell Death and Disease|2013Cited by 57
Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expressionChiara Ciardiello, Alessandra Leone|Oncotarget|2016Cited by 24
Abstract 3721: Critical role of Bevacizumab schedule in combination with chemo-radiotherapy in neo-adjuvant treatment of rectal cancer: Circulating endothelial cells and FDG-PET as markers for early predictionAntonio Avallone, Alfredo Budillon, Elena Di Gennaro et al.|Cancer Research|2010Cited by 0